HSCT for Fanconi anemia in children: Factors that influence early and late results

Bone Marrow Transplantation

Volumn 42, Issue SUPPL. 2, 2008, Pages

  Dalle, J H ^a,b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; THYMOCYTE ANTIBODY;

AUTOSOMAL RECESSIVE INHERITANCE; BONE MARROW DEPRESSION; BURN; CANCER RISK; CARDIOMYOPATHY; CHILD CARE; CYSTITIS; DISEASE PREDISPOSITION; FANCONI ANEMIA; GASTROINTESTINAL HEMORRHAGE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LOW DRUG DOSE; MYELOABLATIVE CONDITIONING; ONSET AGE; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; REVIEW; SURVIVAL RATE; TREATMENT RESPONSE; WHOLE BODY RADIATION;

CHILD; CHILD, PRESCHOOL; CHROMOSOMAL INSTABILITY; FANCONI ANEMIA; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MONITORING, PHYSIOLOGIC; RISK FACTORS; TIME FACTORS; TRANSPLANTATION CONDITIONING;

EID: 55749086421     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.284     Document Type: Review

References (22)

1. D'Andrea AD, Dahl N, Guinan EC, Shimamura A. Marrow failure. Hematology 2002; 58-72.
2. Bagby GC, Alter BP. Fanconi anemia. Semin Hematol 2006; 43: 147-156.
3. Mace G, Briot D, Guervilly JH, Rosselli F. Fanconi anemia: Cellular and molecular features. Pathol Biol (Paris) 2007; 55: 19-28.
4. Soulier J, Leblanc T, Larghero J, Dastot H, Shimamura A, Guardiola P et al. Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood 2005; 105: 1329-1336.
5. van Zeeburg HJ, Sniijders PJ, Pals G, Hermsen MA, Rooimans MA, Bagby G et al. Generation-. and molecular characterization of head and neek squamous cell lines of fanconi anemia patients. Cancer Res 2005; 65: 1271-1276.
6. Alter BP, Greene MH, Velazquez I, Rosenberg PS. Cancer in Fanconi anemia. Blood 2003; 101: 2072.
7. Rosenberg PS, Alter BP, Ebell W. Cancer risks in Fanconi anemia: findings from the German Fancom Anemia Registry. Haematologica 2008; 93: 511-517.
8. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003; 101: 822-826.
9. Berger R, Bernheim A, Gluckman E, Gisselbrecht C. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients. Br J Haematol 1980; 45: 565-568.
10. Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983; 54: 431-440.
11. Gluckman E, Devergie A, Schaison G, Bussel A, Berger R, Sohier J et al. Bone marrow transplantation in Fanconi anaemia. Br J Haematol 1980; 45: 557-564.
12. Socie G, Devergie A, Girinski T, Piel G, Ribaud P, Esperou H, Parquet N et al. Transplantation for Fanconi's anaemia: Long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoracoabdominal irradiation for conditioning. Br J Haematol 1998; 103: 249-255.
13. Flowers ME, Zanis J, Pasquini R, Deeg HJ, Ribeiro R, Longton G et al Marrow transplantation for Fanconi anaemia: Conditioning with reduced doses of cyclophosphamide without radiation. Br J Haematol 1996; 92: 699-706.
14. Gluckman E, Wagner JE. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome. Bone Marrow Transplant 2008, 41: 127-132.
15. Kapelushnik J, Or R, Slavin S, Nagler A. A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia. Bone Marrow Transplant 1997; 20: 1109-1110.
16. Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F, et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007; 109: 2256-2262.
17. Yabe M, Yabe H, Hamanoue S, Inoue H, Matsumoto M, Koike T et al. In vitro effect of fludarabine, cyclophosphamide; and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: Relevance to stem cell transplantation. Int J Hematol 2007; 85: 354-361.
18. Farzin A, Davies SM, Smith FO, Filipovich A, Hansen M, Auerbach AD et al. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: An update of the Cincinnati Children's experience. Br J. Haematol 2007; 136: 633-640.
19. Ayas M, Al-Jefiri A, Al-Seraihi A, Al-Mahr M, Rifai S, Al-Ahmari A et al. Allogeneic stem cell transplantation in Fanconi anemia patients presenting with myelodysplasia and/or clonal abnormality: Update on the Saudi experience. Bone Marrow Transplant 2008; 41: 261-265.
20. Bitan M, Or R, Shapira MY, Aker M, Resnick IB, Ackerstein A et al. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transplant 2006; 12: 712-718.
21. Locatelli F, Zecca M, Pession A, Morreale G, Longoni D, Di Bartolomeo P et al. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: A report from the Italian pediatric group. Haematologica 2007; 92: 1381-1388.
22. Gluckman E, Rocha V, Ionescu I, Bierings M, Harris RE, Wagner J et al Results of unrelated cord blood transplant in fanconi anemia patients: Risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007; 13: 1073-1082.